Skyepharma Plc (SKYEY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | -53,230 | -48,040 | -34,310 |
| Depreciation Amortization | N/A | N/A | 10,010 | 10,610 | 14,120 |
| Other Working Capital | N/A | N/A | -17,800 | -11,210 | 30,270 |
| Other Operating Activity | 0 | 0 | 69,360 | 12,810 | -27,140 |
| Operating Cash Flow | $N/A | $N/A | $8,340 | $-35,830 | $-17,060 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -7,790 | -7,200 | -3,670 |
| Net Acquisitions | N/A | N/A | 0 | 9,200 | 0 |
| Other Investing Activity | 0 | 0 | 1,490 | 5,600 | -180 |
| Investing Cash Flow | $N/A | $N/A | $-6,300 | $7,600 | $-3,850 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | -3,890 | 72,070 | -22,380 |
| Financing Cash Flow | $N/A | $N/A | $-3,890 | $72,070 | $-22,380 |
| Exchange Rate Effect | N/A | N/A | 8,900 | -1,600 | -180 |
| Beginning Cash Position | N/A | N/A | 58,800 | 21,220 | 62,940 |
| End Cash Position | N/A | N/A | 65,850 | 63,460 | 19,450 |
| Net Cash Flow | $N/A | $N/A | $7,040 | $42,240 | $-43,480 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | N/A | 8,340 | -35,830 | -17,060 |
| Free Cash Flow | 0 | 0 | 8,340 | -35,830 | -17,060 |